汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300146 汤臣倍健

交易中 08-14 11:28:57

{"stockData":{"symbol":"300146","market":"SZ","secType":"STK","nameCN":"汤臣倍健","latestPrice":10.03,"timestamp":1786678137000,"preClose":10.08,"halted":0,"volume":9255191,"delay":0,"changeRate":-0.005,"floatShares":1121000000,"shares":1692000000,"eps":0.3836,"marketStatus":"交易中","change":-0.05,"latestTime":"08-14 11:28:57","open":10.11,"high":10.21,"low":10,"amount":93391300,"amplitude":0.0208,"askPrice":10.04,"askSize":38,"bidPrice":10.03,"bidSize":358,"shortable":0,"etf":0,"ttmEps":0.3836,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786678200000},"marketStatusCode":2,"adr":0,"adjPreClose":10.08,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":11.09,"lowLimit":9.07,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1691677031,"isCdr":false,"pbRate":1.57,"roa":"--","peRate":26.147028,"roe":"5.43%","epsLYR":0.47,"committee":0.357919,"marketValue":16968000000,"turnoverRate":0.0083,"status":1,"floatMarketCap":11242000000},"requestUrl":"/m/hq/s/300146/","defaultTab":"news","newsList":[{"id":"2659451169","title":"股市必读：汤臣倍健新发布《关于与专业投资机构共同投资的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659451169","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659451169?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:22","pubTimestamp":1786641732,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，汤臣倍健报收于10.08元，下跌0.49%，换手率1.44%，成交量16.13万手，成交额1.63亿元。公司公告汇总关于与专业投资机构共同投资的进展公告汤臣倍健股份有限公司以自有资金2,000万元投资共青城领屹星途创业投资合伙企业，认缴出资比例为48.78%。领屹星途首期总认缴出资额为4,100万元，实缴出资额为4,005万元。普通合伙人上海领屹私募基金管理有限公司认缴20万元、实缴0万元；其他投资者认缴2,080万元、实缴2,005万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400000916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300146","BK0042","BK0114","BK0107","BK0146","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659180340","title":"汤臣倍健中报营收36.71亿元，聚焦用户价值引领VDS发展新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2659180340","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659180340?lang=zh_cn&edition=full","pubTime":"2026-08-13 11:33","pubTimestamp":1786591994,"startTime":"0","endTime":"0","summary":"近日，全球膳食营养补充剂行业领先企业汤臣倍健对外披露2026年半年度报告。　　据公司半年报显示，报告期内公司实现营业收入36.71亿元，同比增长3.94%，且已实现连续四个季度营收同比走高，拐点趋势愈发凸显，高质量发展底盘有望进一步夯实。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/13/20260813411823.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/13/20260813411823.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangjuejin/20260813/32333690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658928098","title":"汤臣倍健增收不增利，主动迎接阵痛","url":"https://stock-news.laohu8.com/highlight/detail?id=2658928098","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658928098?lang=zh_cn&edition=full","pubTime":"2026-08-12 11:46","pubTimestamp":1786506368,"startTime":"0","endTime":"0","summary":"3年前，汤臣倍健年营收规模曾一度逼近百亿大关，但此后两年营收连续下滑。分季度来看，汤臣倍健增收不增利的趋势愈发明显。今年上半年，汤臣倍健毛利率同比增加1.78个百分点至70.33%，可见产品盈利能力依然强悍。主动调整迎阵痛汤臣倍健在今年上半年出现的业绩变动，是战略调整带来的阶段性阵痛。于是，汤臣倍健在2026年高调宣称再创业和聚焦增长，全方位调整渠道、品类与海外市场布局。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1786408322646476375","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0226","BK0146","300146","BK0114","BK0042","BK0028","BK0107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658969818","title":"汤臣倍健增收不增利，主动迎接阵痛","url":"https://stock-news.laohu8.com/highlight/detail?id=2658969818","media":"斑马消费","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658969818?lang=zh_cn&edition=full","pubTime":"2026-08-11 07:39","pubTimestamp":1786405140,"startTime":"0","endTime":"0","summary":"3年前，汤臣倍健年营收规模曾一度逼近百亿大关，但此后两年营收连续下滑。分季度来看，汤臣倍健增收不增利的趋势愈发明显。今年上半年，汤臣倍健毛利率同比增加1.78个百分点至70.33%，可见产品盈利能力依然强悍。主动调整迎阵痛汤臣倍健在今年上半年出现的业绩变动，是战略调整带来的阶段性阵痛。于是，汤臣倍健在2026年高调宣称再创业和聚焦增长，全方位调整渠道、品类与海外市场布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI0MDY2ODM2MQ==&mid=2247524341&idx=2&sn=482f40ba959abadfe92d1f993b7819d0&chksm=e89a030b65c0fdba618468673d3da314050101b6cc6e58e8f2d4e17169fd4ee16a6e40780dbd&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK0226","BK0114","300146","BK0042","BK0146","BK0107","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658958046","title":"股市必读：汤臣倍健（300146）8月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2658958046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658958046?lang=zh_cn&edition=full","pubTime":"2026-08-11 01:18","pubTimestamp":1786382309,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，汤臣倍健报收于10.11元，上涨0.2%，换手率1.45%，成交量16.24万手，成交额1.64亿元。当日关注点交易信息汇总：8月10日主力资金净流出669.23万元，占总成交额4.08%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100001258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","300146","BK0028","BK0226","BK0114","BK0042","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939835","title":"汤臣倍健（300146）新增【AI智能体】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658939835?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:30","pubTimestamp":1786365019,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，8月10日汤臣倍健新增概念。汤臣倍健主营业务：膳食营养补充剂的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000030640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","159819","BK0114","BK0107","BK0226","BK0042","BK0028","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658871799","title":"汤臣倍健：2026年半年度销售费用率为42.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658871799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658871799?lang=zh_cn&edition=full","pubTime":"2026-08-10 18:21","pubTimestamp":1786357276,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问今年销售费用占比多少，往年四季度投放较多，导致当季利润亏损，今年投放节奏和往年是否相同，四季度利润是否还会亏损或赢利，盼直面解答问题，谢谢汤臣倍健回复：投资者您好！2026年半年度销售费用率为42.06%，公司按照年初既定的收入目标持续推进业务规划落地，全年财务数据情况请以届时公司的定期报告为准。感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000026182.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","300146","BK0028","BK0114","BK0226","BK0107","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658607180","title":"研报掘金丨东吴证券：维持汤臣倍健“买入”评级，收入延续增长，渠道分化明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2658607180","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658607180?lang=zh_cn&edition=full","pubTime":"2026-08-10 13:39","pubTimestamp":1786340385,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0114","BK0226","BK0146","BK0183","601555","BK0009","300146","BK0042","BK0188","BK0276","BK0012","BK0107","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658702476","title":"股市必读：汤臣倍健新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658702476","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658702476?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:38","pubTimestamp":1786297089,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年半年度报告摘要本报告期营业收入3,671,380,055.69元，同比增长3.94%；归属于上市公司股东的净利润603,121,751.13元，同比下降18.11%；归属于上市公司股东的扣除非经常性损益的净利润556,580,506.51元，同比下降19.74%；经营活动产生的现金流量净额178,423,459.28元，同比下降72.21%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0042","300146","BK0114","BK0028","BK0146","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657627021","title":"汤臣倍健(300146)6月30日股东户数6.34万户，较上期减少2.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657627021","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657627021?lang=zh_cn&edition=full","pubTime":"2026-08-08 17:03","pubTimestamp":1786179815,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汤臣倍健披露，截至2026年6月30日公司股东户数为6.34万户，较3月31日减少1484.0户，减幅为2.29%。在食品加工行业个股中，汤臣倍健股东户数高于行业平均水平，截至6月30日，食品加工行业平均股东户数为3.18万户。从股价来看，2026年3月31日至2026年6月30日，汤臣倍健区间跌幅为14.2%，在此期间股东户数减少1484.0户，减幅为2.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080800012859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0146","BK0226","BK0107","BK0028","BK0042","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657364264","title":"【开源食饮每日资讯0807】汤臣倍健拟1.5亿元参投创业投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2657364264","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657364264?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:39","pubTimestamp":1786113540,"startTime":"0","endTime":"0","summary":"公司拟以自有资金1.50亿元投资天津砺思明棠海河创业投资合伙企业，认缴出资比例为22.35%。公司以自有资金8000万元对全资子公司宁波广达盛增资的事项已完成工商变更登记。增资后，宁波广达盛注册资本由5000万元增加至1.30亿元，贝因美仍持有其100%股权。免责声明开源证券股份有限公司是经中国证监会批准设立的证券经营机构，具备证券投资咨询业务资格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2026-08-07/doc-inimpfyi4661981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0107","BK0146","BK0028","300146","BK0226","BK0042","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657564468","title":"汤臣倍健（300146）披露2026年半年度报告，8月7日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657564468","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657564468?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:19","pubTimestamp":1786112388,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，汤臣倍健报收于10.09元，较前一交易日下跌0.1%，最新总市值为170.69亿元。该股当日开盘10.15元，最高10.15元，最低9.95元，成交额达1.49亿元，换手率为1.32%。近日，汤臣倍健股份有限公司披露《2026年半年度报告》。加权平均净资产收益率5.43%，同比下降1.12个百分点。总资产13,440,618,939.27元，较上年度末下降3.86%；归属于上市公司股东的净资产10,874,350,053.59元，较上年度末下降2.11%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700041020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0107","BK0146","BK0028","BK0114","BK0042","300146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657617183","title":"明星产品蛋白粉获“优质蛋白质”评级，汤臣倍健上半年营收36.71亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657617183","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657617183?lang=zh_cn&edition=full","pubTime":"2026-08-07 18:44","pubTimestamp":1786099488,"startTime":"0","endTime":"0","summary":"报告期内，汤臣倍健持续产品科研创新，提升产品差异化竞争优势，2026年上半年公司实现营业收入36.71亿元，同比增长3.94%，主营业务收入36.55亿元，同比增长5.00%，归属于上市公司股东的净利润6.03亿元。其中，汤臣倍健第二季度营收18.03亿元，同比保持正增长，这意味着汤臣倍健已连续四个季度营收同比增长。同时，汤臣倍健持续为不同渠道匹配差异化产品矩阵，上半年商超渠道营收同比增长32%，山姆渠道增速高达101%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026080700033994.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654888966","title":"汤臣倍健（300146）披露对外投资暨关联交易的进展公告，7月28日股价下跌1.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654888966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654888966?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:12","pubTimestamp":1785247943,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘，汤臣倍健报收于9.88元，较前一交易日下跌1.0%，最新总市值为167.14亿元。公司于近日披露《关于对外投资暨关联交易的进展公告》。公告显示，汤臣倍健拟以自有资金7,000万元追加投资Moonshot AI Ltd及/或其关联方、联营公司或重组后主体，本次投资完成后，公司及子公司共投资约17,498.59万元。因公司关联人孙晋瑜女士间接持有标的公司股权，本次追加投资构成关联交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800039668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0226","BK0146","BK0114","BK0042","BK0028","300146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654007135","title":"汤臣倍健(300146.SZ)拟2000万元参投领屹星途基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2654007135","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654007135?lang=zh_cn&edition=full","pubTime":"2026-07-28 21:13","pubTimestamp":1785244387,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汤臣倍健(300146.SZ)发布公告，公司于近日签署《共青城领屹星途创业投资合伙企业(有限合伙)合伙协议》，以自有资金2000万元投资共青城领屹星途创业投资合伙企业(有限合伙)(简称“领屹星途”)，以投资金额为限享有投资收益和承担投资风险。该基金主要投向新一代信息技术、人工智能等战略新兴产业领域的项目。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1473275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0107","BK0042","300146","BK0146","BK0226","BK0114","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654003993","title":"汤臣倍健最新公告：拟以7000万元追加投资MoonshotAILtd","url":"https://stock-news.laohu8.com/highlight/detail?id=2654003993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654003993?lang=zh_cn&edition=full","pubTime":"2026-07-28 18:09","pubTimestamp":1785233395,"startTime":"0","endTime":"0","summary":"汤臣倍健(300146.SZ)公告称，公司拟以自有资金7000万元追加投资MoonshotAILtd，本次投资完成后，公司及子公司共投资标的公司约1.75亿元。本次追加投资构成关联交易，已获董事会审议通过，无需提交股东会审议。标的公司处于高估值赛道，发展阶段尚属早期，存在技术研发不及预期、行业竞争激烈等风险。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800029887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0107","300146","BK0114","BK0028","BK0042","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653088453","title":"汤臣倍健：聚焦主业，致力于实现可持续、有质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2653088453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653088453?lang=zh_cn&edition=full","pubTime":"2026-07-24 17:21","pubTimestamp":1784884885,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问：公司多重利好落地，但股价持续走弱，盘中量化交易扰动明显，请问公司有何市值管理应对措施，是否配合监管监控异常交易？机构多次调研后均无后续动作，公司是否复盘反思，后续如何改善市场认可度？谢谢汤臣倍健回复：投资者您好！股票价格受内外部多种因素影响，公司持续关注市值表现，将聚焦主业，致力于实现可持续、有质量发展，长期创造价值回报广大投资者。感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400030060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0107","BK0146","BK0028","BK0114","BK0042","300146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653276690","title":"汤臣倍健：旗下品牌健安适为肝健康专业品牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2653276690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653276690?lang=zh_cn&edition=full","pubTime":"2026-07-21 18:09","pubTimestamp":1784628555,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问护肝片，枸杞菊花茶，胶原蛋白胶囊，山药茯苓粉，这些产品你们都有吗？年轻人关注的产品你们有哪些？汤臣倍健回复：投资者您好！公司主营膳食营养补充剂业务，旗下品牌健安适为肝健康专业品牌、Yep为高端口服美容品牌。感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100034222.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300146","BK0114","BK0042","BK0226","BK0107","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653752072","title":"汤臣倍健：公司自上市以来现金分红总额超90亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653752072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653752072?lang=zh_cn&edition=full","pubTime":"2026-07-21 18:06","pubTimestamp":1784628377,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问汤臣倍健上市以来一共分红了多少钱啊。汤臣倍健回复：投资者您好！公司自上市以来现金分红总额超90亿元，占累计归属于上市公司股东的净利润的76.18%。感谢关注。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100034026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","BK0114","BK0028","300146","BK0146","BK0042","BK0107"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652647562","title":"DeepSeek真实估值浮出水面？","url":"https://stock-news.laohu8.com/highlight/detail?id=2652647562","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652647562?lang=zh_cn&edition=full","pubTime":"2026-07-20 12:52","pubTimestamp":1784523120,"startTime":"0","endTime":"0","summary":"经测算，DeepSeek首轮融资后的投后估值约为3250亿元至3509亿元。　　近日，九安医疗、开润股份、汤臣倍健三家A股上市公司相继披露间接投资DeepSeek的公告。虽然公告的重点是投资事项，但市场更关注另一项信息，通过持股比例和投资金额反向测算，DeepSeek首轮融资后的投后估值约为3250亿元至3509亿元，与此前传闻接近。　　过去几个月，围绕DeepSeek融资、估值的消息不断流传，但官方始终保持沉默。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-07-20/doc-iniimqsn4911918.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-07-20/doc-iniimqsn4911918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0109","BK0107","BK0251","BK0028","BK0226","BK0146","300146","002432","BK0247","300577","BK0114","BK0042"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786678142871,"stockEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0746},{"period":"3month","weight":-0.0088},{"period":"6month","weight":-0.1322},{"period":"1year","weight":-0.1512},{"period":"ytd","weight":-0.1257}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"汤臣倍健股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"63409人(较上一季度减少2.29%)","perCapita":"17676股","listingDate":"2010-12-15","address":"广东省珠海市金湾区三灶科技工业园星汉路19号","registeredCapital":"169167万元","survey":"　　汤臣倍健股份有限公司的主营业务是膳食营养补充剂的生产销售。公司的主要产品是片剂、粉剂、胶囊。公司珠海透明工厂于2017年设立了国家博士后科研工作站汤臣倍健分站；2018年被评为国家AAAA级旅游景区和国家绿色工厂；2019年建成行业第一家营养探索馆，同年设立广东省院士专家企业工作站；2023年获全国质量标杆、第二届中国标杆智能工厂等称号；2024年获全国产品和服务质量诚信示范企业称号，入选广东省诚信兴商典型案例。2025年，汤臣倍健检测中心获“广东省先进集体”称号。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汤臣倍健,300146,汤臣倍健股票,汤臣倍健股票老虎,汤臣倍健股票老虎国际,汤臣倍健行情,汤臣倍健股票行情,汤臣倍健股价,汤臣倍健股市,汤臣倍健股票价格,汤臣倍健股票交易,汤臣倍健股票购买,汤臣倍健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}